MétaCan
Menu
Back to cohort
Record W2587113208 · doi:10.1093/neuonc/now212.731

RTHP-05. INTRAOPERATIVE RADIOTHERAPY (IORT) USING LOW-ENERGY X-RAYS IN A COHORT OF PREDOMINANTLY INCOMPLETELY RESECTED NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (INTRAGO TRIAL)

2016· article· en· W2587113208 on OpenAlexaff
Frank A. Giordano, Stefanie Brehmer, Bettina Mürle, Grit Welzel, Elena Sperk, Anke Keller, Yasser Abo‐Madyan, Sven Clausen, David Schneider, Carsten Herskind, Marcel Seiz‐Rosenhagen, Christoph Groden, Peter Schmiedek, Martin Glas, Daniel Hänggi, Kevin Petrecca, Frederik Wenz

Bibliographic record

VenueNeuro-Oncology · 2016
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsMcGill UniversityMontreal Neurological Institute and Hospital
Fundersnot available
KeywordsMedicineTolerabilityRadiation therapyClinical endpointProgression-free survivalSurgeryRadiosurgeryAdverse effectChemotherapyUrologyInternal medicineRandomized controlled trial

Abstract

fetched live from OpenAlex

Local recurrence remains the predominant pattern of failure in glioblastoma multiforme (GBM), indicating that residual clonogenic tumor cells may need to be targeted by more intensive therapy of the tumor cavity. We performed a phase I/II trial (NCT02104882) to evaluate safety and tolerability of intraoperative radiotherapy (IORT) with 20-40 Gy of low-energy photons (50 kV) in addition to standard radiochemotherapy. The primary endpoint was occurrence of dose-limiting toxicities (DLT) within 3 months after IORT (wound healing deficits, cerebral bleeding/ischemia, brain necrosis and early termination of radiochemotherapy). Secondary endpoints were progression-free survival (PFS), local PFS (≤ 1cm to the cavity) and overall survival (OS). Fourteen patients with histologically confirmed IDH1wt GBM were included (median FU 12.4 months), 12 underwent incomplete resection, 9 had unmethylated MGMT promoters, 6 had unresectable satellites and 3 did not receive per-protocol treatment (PPT). No DLTs were observed at any dose level within the predefined time frame. The majority of grade 3-5 adverse events (21 of 25) were deemed related to chemotherapy or tumor progression. Radionecrosis was diagnosed in 3 patients which occurred after the predefined time frame. The median PFS was 10.3 months (95%CI: 5.2-15.4) in all and 11.4 months (95%CI: 9.8-13.0) in PPT patients. The median local PFS was 13.4 m (95%CI: 9.7-17.1) in all and 14.5 m (95%CI: 11.3-17.7) in PPT patients. The median OS was 14.5 m (95%CI: 9.8-19.2) for all and 16.5 m (95%CI: 11.5-21.5) for PPT patients. One distant response was observed without any change of treatment. IORT with low-energy photons in addition to standard therapy is safe and tolerable. Despite multiple poor prognostic factors, median and local PFS compare favourably to historic data (mPFS was 6.9 m in the EORTC/NCIC trial). The technique is now tested in a multinational randomized phase III trial (NCT02685605).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.302
Teacher spread0.280 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicGlioma Diagnosis and TreatmentFrench-language works237,207